|
I have been following with great interest the posts about getting Herceptin after 12 months of chemo. I am curious if anyone has contacted Sloan-Kettering, MD Anderson, Mayo Clinic or any of the other cancer research facilities to see what they have to say about whether Her2+, node positive, B/C patients with no known recurrence who never received Herceptin should get it now. Given that we are a group who are unlikely to be the subject of a clinical trial, let's please talk more about what people are doing and how the doctors are grappling with us. If oncologists are willing to give Herceptin to those of us who are far out from chemo, are they recommending Herceptin alone or should another round of Taxol be given with it (and if not, why not)?
I know this is getting a lot of coverage here, but it is a question that is so important to so many of us.
Please everyone, let's discuss this.
Thank you.
Katie
|
Threaded Mode